-
Article
Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic
The coronavirus SARS-CoV-2 is highly contagious. Hydroxychloroquine (HCQ) has in vitro activity against SARS-CoV-2. The FDA authorized emergency use of HCQ against COVID-19. HCQ may have dose-related cardiotox...
-
Article
Open AccessBacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors
Coronavirus SARS-CoV-2 causes COVID-19 illness which can progress to severe pneumonia. Empiric antibacterials are often employed though frequency of bacterial coinfection superinfection is debated and concerns...
-
Article
Open AccessThe future is now: our experience starting a remote clinical trial during the beginning of the COVID-19 pandemic
The World Health Organization declared the outbreak of SARS-CoV-2 a pandemic on February 11, 2020. This organism causes COVID-19 disease and the rapid rise in cases and geographic spread strained healthcare sy...
-
Article
Quinolone Susceptibility of Multiply-Resistant Flavobacterium meningosepticum Clinical Isolates in One Urban Hospital
-
Article
Oral and/or Intravenous Ciprofloxacin for Treatment of Multiply-Resistant Flavobacterium meningosepticum Septicaemia
-
Article
ENZYME REPLACEMENT THERAPY: DIRECTING EXOGENOUS ENZYME TO THE LIVER
Mammalian liver possesses sites, not shared by other organs, which bind several glycoproteins whose terminal sugars are galactose. Such proteins are taken up rapidly—and almost exclusively—by the liver followi...
